MSB 7.69% $1.19 mesoblast limited

Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-235

  1. 401 Posts.
    lightbulb Created with Sketch. 34
    Is this what Mesoblast will be seeking for. Re: they will ask for a meeting with the FDA within 30 days?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.